Clinical Data, Inc. to Present at Piper Jaffray Health Care Conference.
NEWTON, Mass. -- Clinical Data, Inc. (NASDAQ: CLDA), today announced that Drew Fromkin, President and Chief Executive Officer, will be presenting a brief corporate overview at the 21st Annual Piper Jaffray Health Care Conference. Clinical Data's presentation will take place at 12:00 p.m. EST on Tuesday, December 1, 2009 at The New York Palace Hotel, New York, NY.
A live audio and archived webcast of the Company's presentation can be accessed through Clinical Data's website at www.clda.com.
About Clinical Data, Inc.
Clinical Data develops first-in-class and best-in-category therapeutics. The Company is advancing its late-stage drug candidates for central nervous system disorders and cardiovascular diseases, to be followed by promising drug candidates in other major therapeutic areas. Clinical Data is utilizing its drug development and biomarker expertise to develop products with enhanced efficacy and tolerability to improve patient health and reduce costs. To learn more, please visit the Company's website at www.clda.com.
|Printer friendly Cite/link Email Feedback|
|Article Type:||Conference news|
|Date:||Nov 24, 2009|
|Previous Article:||IA Global Announces Delayed Filing of Form 10-Q and NYSE AMEX Deficiency Notice.|
|Next Article:||Research and Markets: Innovations in Oncology Diagnostics: Technological Advances, Growth Opportunities and Future Market Outlook.|